Recruiting Phase I/II Trial of Pemigatinib in Combination With Atezolizumab and Bevacizumab for Treatment of Advanced Cholangiocarcinoma With FGFR2 Fusion NCT06439485 Conditions Advanced Cholangiocarcinoma, FGFR2 Fusion Locations MD Anderson Cancer Center — Houston, Texas, United States View Trial Details
Completed Study to Evaluate the Efficacy and Safety of TT-00420 (Tinengotinib) in Cholangiocarcinoma NCT04919642 Conditions Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +7 more Locations Providence Cancer Center — Anchorage, Alaska, United States City of Hope — Duarte, California, United States University of California, Los Angeles, School of Medicine — Santa Monica, California, United States USO Oncology Network- Rocky Mountain Cancer Centers — Denver, Colorado, United States View all 32 locations View more locations Show fewer locations Loading locations... View Trial Details
